Much genetic and biochemical evidence exists to support the view that amyloid-β (Aβ) is the antecedent and the potential initiator of a pathologic cascade that includes tau deposition, neurodegeneration, and ultimately dementia [2,3]. The gene discussed is MAPT; the disease is dementia.